Related Experiment Video
Updated: Mar 28, 2026

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
Published on: June 14, 2019
Implementation of HPV testing in Latin America
Jose Jeronimo1, Francesca Holme1, Rose Slavkovsky1
1PATH, 2201 Westlake Ave., Seattle, WA 98121, USA.
Human papillomavirus (HPV) testing offers a viable strategy for cervical cancer screening in Latin America. Pilot programs demonstrate high efficacy and feasibility, paving the way for wider implementation.
Area of Science:
- Oncology
- Public Health
- Infectious Diseases
Background:
- Cervical cancer remains a significant health burden for women in Latin America, largely due to challenges in implementing effective screening programs.
- Persistent infection with oncogenic human papillomavirus (HPV) is the primary cause of cervical cancer.
Purpose of the Study:
- To evaluate the feasibility and efficacy of implementing HPV testing for population-level cervical cancer screening in resource-constrained Latin American countries.
- To identify barriers and requirements for large-scale HPV screening implementation in the region.
Main Methods:
- Review of pilot programs in Nicaragua, Mexico, and Argentina assessing HPV testing and self-sampling.
- Analysis of experiences from El Salvador, Guatemala, Honduras, and Nicaragua in institutionalizing HPV testing.
- Assessment of regional opportunities, including existing screening programs and procurement mechanisms.
Main Results:
- Pilot programs demonstrated high efficacy in detecting precancerous cervical lesions, with good feasibility and acceptance of self-sampling.
- Several countries are actively moving towards population-level HPV testing implementation.
- Key challenges include updating guidelines, strengthening treatment capacity, and ensuring quality assurance for HPV testing.
Conclusions:
- Despite implementation challenges, significant opportunities exist in Latin America for successful HPV screening adoption.
- Existing government-funded programs and regional collaborations can facilitate the integration of HPV testing.
- Widespread adoption of HPV testing in national programs is anticipated within the next three to five years.
More Related Videos
13:41Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
10:26RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
Published on: March 11, 2014
Related Concept Videos
Cancer Prevention
Some...
Cancer Prevention